register free | resend password

Pressemitteilungen zu dem Thema pivotal


Unterkategorien

PresseMitteilungen zu dem Schlagwort pivotal


Redis Labs Teams Up with Pivotal to Automate Data Microservices for the Enterprise

MOUNTAIN VIEW, CA -- (Marketwired) -- 06/22/17 -- Redis Labs, the home of Redis and provider of Redis Enterprise, today announced a new Redis Enterprise Pack for Pivotal Cloud Foundry®, one of the world''s most powerful cloud-native application platforms. This integration automates management using BOSH, and allows Pivotal Cloud Foundry customers to deploy as a data microservice within their platform, enabling users to build highly responsive applications without having to separately ...


22.06.2017

Pivotal Marketing Ventures offers super helpful and honest Internet Marketing Reviews that can broaden the promotion vision for every brand

Pivotal Marketing Ventures, a resourceful and super proficient marketing and web promotion service provider, makes available second to none marketing services, SEO and training resources for gaining remarkable brand visibility and recognition. We are living in an era in which things are impressively evolving and if an entrepreneur strives to be always visible to its clients, he needs to find the best ways to stand out from the crowd and to significantly differentiate his brand and products from ...


13.03.2017

ForgeRock and Pivotal Team Up to Bring Customer Identity and Access Management Capabilities to Pivotal Cloud Foundry

SAN FRANCISCO, CA -- (Marketwired) -- 11/17/16 -- ®, the leading open provider of identity management solutions, today announced that it is collaborating with , the company accelerating digital transformation for enterprises, to deploy its customer identity and access management solutions to , cloud-native platforms. The ForgeRock Service Broker for Pivotal Cloud Foundry allows externally deployed ForgeRock solutions to protect applications and microservices running in Pivotal Cloud Foundry. ...


17.11.2016

Redis Labs Brings In-Memory Enterprise-Grade Redis Databases to Pivotal Cloud Foundry

MOUNTAIN VIEW, CA -- (Marketwired) -- 05/24/16 -- , the home of Redis, the world''s most popular in-memory NoSQL database, and ®, the company accelerating digital transformation for enterprises, today announced the beta availability of the tile on the . This new integration delivers the highly available and seamlessly scalable Redis on ®, enabling enterprises to build and deploy world-class enterprise applications on a stable, high performance and zero operational hassle database.Piv ...


24.05.2016

Iron.io Joins Cloud Foundry Foundation

SAN FRANCISCO, CA -- (Marketwired) -- 10/21/15 -- Iron.io today announced that it is joining the , home of the industry standard Platform-as-a-Service (PaaS). As a Foundation member, Iron.io brings its job queuing, scheduling, and processing capabilities to the Cloud Foundry platform, providing developers a domain-specific environment for handling asynchronous workloads at scale within their applications."Iron.io is excited to formally join the vibrant Cloud Foundry community, and contribu ...


21.10.2015

AllSeen Alliance Deepens IT Infrastructure and Cloud Computing Expertise for IoT

SAN FRANCISCO, CA -- (Marketwired) -- 07/15/15 -- The , a cross-industry collaboration to advance the Internet of Everything through an open source software project, today announced 13 new members have joined the initiative including industry giants IBM and Pivotal.Analyst predictions estimate that four billion people will be connected to more than 30 billion devices, services and applications by 2020. This level of connectivity will create unprecedented bandwidth demand on IT infrastructure, h ...


15.07.2015

Review of Stephen Bigalow’s Pivotal Cash Bonanza to Trade Options Using Candlesticks Announced

FOR IMMEDIATE RELEASE Manchester, UK (May 12, 2015) – People who are familiar with some of the basic elements of technical price analysis have possibly used candlestick charts, often it is called candlestick trading in some of the market analysis, and is generally because these charts make it very easy to make a broad assessment with a quick glance. Mr. Bigalow is an expert in professional trading and has already advised professional traders, money managers, mutual funds as well as hedge funds. ...


12.05.2015

Quaero Extends the Reach of AdVantage(TM) With Support for Pivotal

CHARLOTTE, NC and BURLINGTON, MA -- (Marketwired) -- 03/12/15 -- The unprecedented amount of available data on consumer behavior is a double-edged sword for those in the digital media industry. On one hand they now have the insight required to execute more personalized, more profitable campaigns. On the other, utilizing and accessing all the available data is increasingly difficult as marketers must not only contend with the rapid creation of new data, but also a myriad of legacy point solution ...


12.03.2015

Pivotal Selects Piston to Provide OpenStack Infrastructure for Cloud Foundry Ecosystem

SAN FRANCISCO, CA -- (Marketwired) -- 08/22/13 -- , the enterprise OpenStack™ company, today announced that it is now the community OpenStack infrastructure provider for ™, the industry's Open Platform-as-a-Service (PaaS). Piston will continue to be one of Pivotal's partners for rapid Cloud Foundry deployments, and its Co-founder and CTO, Joshua McKenty, will serve on the Cloud Foundry Advisory Board.Pivotal selected Piston to provide the initial community OpenStack infrastructure bec ...


22.08.2013

RESAAS, Pivotal Therapeutics and Plus8 Global Investor Evening in Toronto, June 6th

TORONTO, ONTARIO -- (Marketwired) -- 05/30/13 -- Our next Proactive Investors One2One Forum, sponsored by the CNSX, will take place June 6th as we showcase another batch of exciting companies in Toronto. The event kicks off at 5:30 pm in the East Ballroom at the Toronto Region Board of Trade - 77 Adelaide Street West.Presenting will be the directors of () and () and ()------RESAAS's social network is designed to allow real-time updating of property listings as well as the ability to syn ...


30.05.2013

BTI Systems Adds Former VMware Executive Tod Nielsen to Board of Directors

OTTAWA and BOSTON, MA -- (Marketwired) -- 04/16/13 -- Following closely on ' introduction of -- an open, software-rich platform designed to significantly improve cloud networking performance by combining network intelligence and application awareness with significantly expanded capacity and scale -- the company today announced that software industry visionary Tod Nielsen is joining its board of directors.Based in Silicon Valley and globally recognized for his combination of strategic visi ...


16.04.2013

Global Capacity Announces Management Changes Co-Founder and CEO Patrick Shutt Transitions to Vice Chairman of the Board

CHICAGO, IL -- (Marketwire) -- 10/01/12 -- , the world's leading telecommunications information and logistics company, announces that Co-Founder and CEO Patrick Shutt will transition to a new role as Vice Chairman of the Board, and COO Jack Lodge has been promoted to President. Both changes are effective October 1, 2012.In his new role as Vice Chairman, Mr. Shutt will continue to help guide the strategic direction of Global Capacity, while also pursuing new entrepreneurial ventures in the ...


01.10.2012

Global Capacity Expands One Marketplace Access Exchange, Establishes New Point of Presence in New York City

CHICAGO, IL -- (Marketwire) -- 10/01/12 -- , the leading telecommunications information and Logistics Company, announces today the expansion of the with a new Point of Presence (PoP) at 60 Hudson Street, New York. The expansion includes network interconnections with , the premier provider of fiber optic-based network solutions, and , a leading provider of global interconnectivity, cloud enablement services and data center solutions.Driving Global Capacity's expansion is the ever-growing d ...


01.10.2012

SciBase Announces Positive Top-Line Results From Pivotal Study

STOCKHOLM, SWEDEN -- (Marketwire) -- 07/31/12 -- Editors Note: There is a photo associated with this press release.The Swedish medtech company, SciBase, today announced top-line results of its pivotal study SIMPS of Nevisense, a unique non-invasive point-of-care device for detection of Malignant Melanoma, the deadliest form of skin cancer. 22 clinics across Europe and the US participated in the blinded study which was conducted under an IDE approval from the FDA. The study included 2 400 skin l ...


31.07.2012

Pivotal Therapeutics Announces 2011 Financial Results

WOODBRIDGE, ONTARIO -- (Marketwire) -- 04/30/12 -- Pivotal Therapeutics Inc. (OTCQX: PVTTF)(CNSX: PVO), a specialty pharmaceutical company with a focus on the treatment of cardiovascular disease, today announced its operational highlights and financial results for the fiscal year ended December 31, 2011. All dollar amounts referenced herein are in Canadian dollars unless otherwise stated.Financial ReviewThe period of twelve months ended December 31, 2011 represents the Company's first ann ...


30.04.2012

Pivotal Therapeutics Inc. Begins Trading on the OTCQX

WOODBRIDGE, ONTARIO -- (Marketwire) -- 04/03/12 -- Pivotal Therapeutics Inc. (CNSX: PVO)(OTCQX: PVTTF), a specialty pharmaceutical company with a focus on the treatment of cardiovascular disease, is pleased to announce today that the company is now trading on the highest tier of the OTC Markets Group, OTCQX®, under the trading symbol PVTTF, effective at the market open on Tuesday, April 3, 2012."We are very excited to not only be trading on a U.S. exchange, but to be trading on the OTC ma ...


03.04.2012

Pivotal Therapeutics Inc. Grants Incentive Stock Options

WOODBRIDGE, ONTARIO -- (Marketwire) -- 04/02/12 -- Pivotal Therapeutics Inc. (CNSX: PVO), a specialty pharmaceutical company with a focus on the treatment of cardiovascular disease has granted a total of 200,000 incentive stock options to an external director of the Company on March 29, 2012. The options are exercisable into common shares at an exercise price of $0.29 over a term of five years. The stock options were granted to an external director for his efforts in assisting the Company with ...


02.04.2012

Pivotal Therapeutics Inc. Information to be Available through S&P Capital IQ's Market Access Program

WOODBRIDGE, ONTARIO -- (Marketwire) -- 03/08/12 -- Pivotal Therapeutics Inc. (CNSX: PVO), announced today that its company information will be made available via S&P Capital IQ's Market Access Program, an information distribution service that enables subscribing publicly traded companies to have their company information disseminated to users of S&P Capital IQ's MarketScope Advisor. The company information to be made available through this program includes share price, volume ...


08.03.2012

Pivotal Therapeutics Exhibiting at The American College of Cardiology 61st Annual Scientific Session & Expo

WOODBRIDGE, ONTARIO -- (Marketwire) -- 02/29/12 -- Pivotal Therapeutics Inc. (CNSX: PVO), a specialty pharmaceutical company with a focus on the treatment of cardiovascular disease, is pleased to announce that the company will be exhibiting at the 61st Annual Scientific Session & Expo of The American College of Cardiology ("ACC") in Chicago, March 24-27, 2012, Booth #24020.The annual meeting of the ACC is unsurpassed among clinical cardiology meetings and is one of the most highl ...


29.02.2012

DGAP-News: WILEX AG: FDA approves protocol amendment needed to conduct the final analysis of the pivotal RENCAREX(R) Phase III trial

DGAP-News: WILEX AG / Key word(s): Miscellaneous WILEX AG: FDA approves protocol amendment needed to conduct the final analysis of the pivotal RENCAREX(R) Phase III trial 27.02.2012 / 07:17 --------------------------------------------------------------------- PRESS RELEASE FDA approves protocol amendment needed to conduct the final analysis of the pivotal RENCAREX(R) Phase III trial Munich, Germany, 27 February 2012. WILEX AG (ISIN DE0006614720 / WL6 / FSE) today announced that the US Food ...


27.02.2012

Pivotal Therapeutics Files Five International Patent Applications

WOODBRIDGE, ONTARIO -- (Marketwire) -- 02/22/12 -- Pivotal Therapeutics Inc. (CNSX: PVO), a specialty pharmaceutical company with a focus on the treatment of cardiovascular disease and overall health, announced today that it has filed five international patent applications under the Patent Cooperation Treaty (PCT), directed toward its novel lead product VASCAZEN™, and combinations thereof with certain cardiovascular treatment agents. The PCT is an international patent application. A PCT applic ...


22.02.2012

Taglich Brothers Initiates Coverage on Pivotal Therapeutics Inc.

NEW YORK, NY -- (Marketwire) -- 02/08/12 -- announces it initiated coverage of Pivotal Therapeutics Inc.(CNSX: PVO) headquartered in Woodbridge, Ontario, Canada was established in 2010. Pivotal is a development stage specialty pharmaceutical company that is currently focused on the commercialization of Vascazen, an FDA-approved prescription Omega 3 medical food product developed to reduce risk factors that led to adverse coronary events, including sudden death. Vascazen is the first of a rang ...


08.02.2012

Pivotal Therapeutics Inc. Review and Update from the CEO

WOODBRIDGE, ONTARIO -- (Marketwire) -- 02/02/12 -- Pivotal Therapeutics Inc. (CNSX: PVO), a specialty pharmaceutical company with a focus on the treatment of cardiovascular disease and overall health, today reports a Review and Update from the CEO.Dear Fellow ShareholdersI welcome this opportunity to briefly review the progress our Company has made during 2011 and our objectives for 2012.Pivotal accomplished a number of key milestones during 2011; the two most significant being our commercial ...


02.02.2012

Pivotal Therapeutics Receives Product License in Canada for OMAZEN(TM)

WOODBRIDGE, ONTARIO -- (Marketwire) -- 12/05/11 -- Pivotal Therapeutics Inc. (CNSX: PVO), a specialty pharmaceutical company with a focus on the treatment of cardiovascular disease and overall health, today reports having received its Product License and NPN number from Health Canada, for OMAZEN™, hereby authorizing the sale of product in the Canadian market.The Natural Health Products Directorate ("NHPD") has concluded that OMAZEN™ is in compliance pursuant to Section 7 of the Natur ...


05.12.2011

Pivotal Therapeutics Launches Lead Therapeutic VASCAZEN(TM) in North America

WOODBRIDGE, ONTARIO -- (Marketwire) -- 11/22/11 -- Pivotal Therapeutics Inc. (CNSX: PVO), a specialty pharmaceutical company with a focus on the treatment of cardiovascular disease, is pleased to announce completion of another significant development milestone, the North American Launch of its lead therapeutic VASCAZEN™, at the American Heart Association ("AHA") Scientific Sessions 2011 last week in Orlando, Florida."The North American launch of VASCAZEN™ is a significant milest ...


22.11.2011

DGAP-News: WILEX AG: ARISER Independent Data Monitoring Committee (IDMC) recommends conducting the final analysis of the pivotal Phase III trial with RENCAREX(R)

DGAP-News: WILEX AG / Key word(s): Research Update WILEX AG: ARISER Independent Data Monitoring Committee (IDMC) recommends conducting the final analysis of the pivotal Phase III trial with RENCAREX(R) 21.11.2011 / 19:23 --------------------------------------------------------------------- WILEX AG: ARISER Independent Data Monitoring Committee (IDMC) recommends conducting the final analysis of the pivotal Phase III trial with RENCAREX(R) - Review of study status led the IDMC to recommend p ...


21.11.2011

Pivotal Therapeutics Inc. Announces Strategic Partnership With Medical Food Industry Leader

WOODBRIDGE, ONTARIO -- (Marketwire) -- 10/06/11 -- Pivotal Therapeutics Inc. (CNSX: PVO), a specialty pharmaceutical company with a focus on the treatment of cardiovascular disease, is pleased today to announce that it has engaged Phoenix Healthcare LLC as its contract sales force partner. The Partnership, covers the recruitment and development of a dedicated contract sales force specializing in medical food sales for Pivotal's lead therapeutic, VASCAZEN™."This is an exciting step fo ...


06.10.2011

Pivotal Therapeutics Inc. Raises $2,679,098 Via Warrant Exercise

WOODBRIDGE, ONTARIO -- (Marketwire) -- 09/22/11 -- Pivotal Therapeutics Inc. (CNSX: PVO), a specialty pharmaceutical company with a focus on the treatment of cardiovascular disease, is pleased to announce it has raised a total of CDN $2,679,098 in net proceeds to the company through the successful exercise of 10,716,392 common stock purchase warrants. The warrants, issued as part of a non-brokered private placement issued on November 30, 2010 and February 2, 2011, were exercised at CDN $0.25 p ...


22.09.2011

Pivotal Therapeutics Inc. Announces 2011 Second Quarter Results Grants Incentive Stock Options

WOODBRIDGE, ONTARIO -- (Marketwire) -- 08/29/11 -- Pivotal Therapeutics Inc. (CNSX: PVO) today reported its unaudited financial results for the second quarter ended June 30, 2011. The Company's second quarter Condensed Interim Consolidated Financial Statements and Management Discussion and Analysis ("MD&A") has been filed with the System for Electronic Document Analysis and Retrieval ("SEDAR") and will be available at .Additionally, in recognition of the many strat ...


29.08.2011

Pivotal Therapeutics Inc. Engages US Investor Relations Firm

TORONTO, ONTARIO -- (Marketwire) -- 08/18/11 -- Pivotal Therapeutics Inc. (CNSX: PVO), a specialty pharmaceutical company with a focus on the treatment of cardiovascular disease, is pleased to announce today that it has engaged The Shoreham Group, LLC to provide investor relations and strategic advisory services. Pivotal's lead product is a proprietary prescription-grade Omega-3 product, formulated with a unique Eicosapentaenoic (EPA) to Docosahexaenoic (DHA) ratio of ultra-high purity, f ...


18.08.2011

Pivotal Therapeutics Inc. Extends Warrant Call

TORONTO, ONTARIO -- (Marketwire) -- 08/04/11 -- Pivotal Therapeutics Inc. (CNSX: PVO), the developer of a proprietary prescription-grade Omega-3 product, formulated with a unique Eicosapentaenoic (EPA) to Docosahexaenoic (DHA) ratio of ultra-high purity, for utility as an aid in the dietary management of Omega-3 deficient cardiovascular disease patients through elevating EPA and DHA Omega-3 fatty acids, reported today that it is extending the exercise period for the call on Pivotal Therapeutic ...


04.08.2011

Galvanize and Pivotal Team Up to Provide Students Access to Pivotal Cloud Foundry

SAN FRANCISCO, CA -- (Marketwired) -- 12/14/15 -- , an education company focused on data science, web development and entrepreneurship, and ®, the company accelerating digital transformation for enterprises, today announced a collaborating to provide hundreds of Galvanize students with access to the industry''s fastest growing Cloud Native platform -- Cloud Foundry. Galvanize will be integrating ® and Cloud Native development modules into Galvanize Full Stack, its 23-week web developm ...


14.12.2015



All members: 9 438
Register today: 0
Register yesterday: 0
Members online: 0
Guests online: 65


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.